Skip to main content

Table 2 PCR-positive assays in serially-taken peripheral blood samples.

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

AJCC STAGE (patients)

PCR-positive assays

No. of PDs (%)

 

0 (%)

1 (%)

2 (%)

3 (%)

4 (%)

5 (%)

 

I (72)

6 (8)

30 (42)

22 (31)

9 (12)

4 (6)

1 (1)

12 (17)

IA (50)

3 (6)

21 (42)

15 (30)

7 (14)

3 (6)

1 (2)

8 (16)

IB (22)

3 (14)

9 (41)

7 (32)

2 (9)

1 (4)

0 (0)

4 (18)

II (49)

4 (8)

10 (20)

19 (39)

12 (25)

2 (4)

2 (4)

17 (35)

IIA (36)

2 (5.5)

8 (22)

14 (39)

9 (25)

2 (5.5)

1 (3)

11 (31)

IIB-IIC (13)

2 (15)

2 (15)

5 (39)

3 (23)

0 (0)

1 (8)

6 (46)

III (28)

4 (14)

6 (21)

8 (29)

6 (21)

3 (11)

1 (4)

20 (71)

TOTAL (149)

14 (9)

46 (31)

49 (33)

27 (18)

9 (6)

4 (3)

49 (33)

  1. PD, progression disease